Drug class in one race
CD47 drugs for Multiple Myeloma
2 tracked CD47 drugs in the Multiple Myeloma race. The class explanation lives on the CD47 page; the full indication pipeline across every mechanism is on the Multiple Myeloma page.
1 Phase 11 preclinical / unstaged
Head-to-head evidence: Evorpacept vs Maplirpacept